Skip to main content
Skip to content
Case File
efta-01522155DOJ Data Set 10Other

EFTA01522155

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01522155
Pages
1
Persons
0
Integrity

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
GHISLAINE MAXWELL- OAP FDG ACCT. For the Period 2/1/12 to 7./29/12 Price Quantity Value Adjusted Tax Cost Unrealized Gain/Loss Est. Annual Inc. Yield Original Cost Accrued Div. US Large Cap Equity RAYTHEON CO 50.52 163.000 8,234/6 8,815.36 1,419.40 280.36 3.40% 755111-50.7 RTh WALGREEN CO 33.16 197.000 6,53252 6550.56 (18.04) 177.30 2.71% 931422-10-9 WAG 44.33 Total US Large Cap Equity 6148,12238 5130.765.52 517.356.86 54/44.14 3.20% $833.30 Concentrated & Other Equity ABBOTT LABORATORIES 56.61 148.000 8,378.28 7,308.74 1,069.54 301.92 a 60% 002824-10-0 AST PEOPLE'S UNITED FINANCIAL INC 12.59 571.000 7,188.89 6.915.76 273.13 359.73 5.00% 712704-10-5 PBCT Total Concentrated & Other Equity $15.567.17 514,224.50 $1,342.67 5661.65 4.25% JP Morgan Page 6 of 12 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00049643 SDNY_GM_00318841 EFTA01522155

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.